Pulse Biosciences Inc (PLSE)
17.68
+1.56
(+9.68%)
USD |
NASDAQ |
Nov 22, 16:00
17.68
0.00 (0.00%)
After-Hours: 20:00
Pulse Biosciences Total Assets (Quarterly): 49.16M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 49.16M |
| December 31, 2023 | 59.15M |
| September 30, 2023 | 65.94M |
| June 30, 2023 | 74.76M |
| March 31, 2023 | 70.22M |
| December 31, 2022 | 77.88M |
| September 30, 2022 | 87.57M |
| June 30, 2022 | 40.60M |
| March 31, 2022 | 39.53M |
| December 31, 2021 | 54.25M |
| September 30, 2021 | 67.15M |
| June 30, 2021 | 80.04M |
| March 31, 2021 | 80.56M |
| December 31, 2020 | 41.29M |
| September 30, 2020 | 49.70M |
| June 30, 2020 | 58.38M |
| March 31, 2020 | 31.84M |
| Date | Value |
|---|---|
| December 31, 2019 | 41.92M |
| September 30, 2019 | 48.70M |
| June 30, 2019 | 57.03M |
| March 31, 2019 | 63.45M |
| December 31, 2018 | 70.64M |
| September 30, 2018 | 32.73M |
| June 30, 2018 | 39.53M |
| March 31, 2018 | 44.80M |
| December 31, 2017 | 49.82M |
| September 30, 2017 | 54.12M |
| June 30, 2017 | 27.95M |
| March 31, 2017 | 28.57M |
| December 31, 2016 | 26.31M |
| September 30, 2016 | 28.83M |
| June 30, 2016 | 31.06M |
| March 31, 2016 | 12.82M |
| December 31, 2015 | 14.32M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
31.84M
Minimum
Mar 2020
87.57M
Maximum
Sep 2022
59.44M
Average
58.77M
Median
Total Assets (Quarterly) Benchmarks
| NeuroOne Medical Technologies Corp | 4.913M |
| SINTX Technologies Inc | 11.30M |
| Nutriband Inc | 13.63M |
| enVVeno Medical Corp | 50.39M |
| Beyond Air Inc | 53.01M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.88M |
| Shareholders Equity (Quarterly) | 36.29M |